FEBUXOSTAT BAUSCH
80MG TBL FLM 84
| SÚKL code | 0242786 |
|---|---|
| Name of the product | FEBUXOSTAT BAUSCH |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | FEBUXOSTAT BAUSCH |
| Supplement | 80MG TBL FLM 84 |
| Strenght | 80MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 84 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | FEBUXOSTAT (FEBUXOSTATUM) |
| ATC group | M04AA03 |
| ATC group name | FEBUXOSTAT |
Marketing authorisation information
| Registration Number | 29/ 232/19-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 11. 2022 |
| MA Holder | Bausch Health Ireland Limited, Dublin |
| MA Holder country | IRSKO |
| Actual MA holder | Laboratorios Liconsa, S.A., Madrid |
| Actual MA holder country | ŠPANĚLSKO |
cz